Mylan Rolls out Herceptin Biosimilar in India - Analyst Blog

03-02-2014 NASDAQComments (0)


A prevalent phenomenon in the medical sector is the shift in focus of several companies on the highly lucrative biosimilars (generic versions of biologics) market. Biosimilars are expected to be a significant growth driver in the generics industry in ...

Read more on NASDAQ

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top